Christian Baumann: Clinical Trials

8 trials sponsored by Christian Baumann, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 withdrawn. 5 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Unknown 2
Phase 22Completed 2

Follow Christian Baumann: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integration of Auditory, and Deep Brain Stimulation to Enhance Deep Sleep in Parkinson's Disease
Acoustic stimulation - Parkinson Disease
Not applicableCompletedChristian Baumann152021-11-102023-09-21
Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson Disease
MHSL- SleepBand, Sham - Parkinson Disease, Mild Cognitive Impairment
Not applicableUnknownChristian Baumann122020-10-202021-07-06
Decision-making After Sleep Restriction
Sleep restriction, Acoustic stimulation - Sleep Restriction
Not applicableCompletedChristian Baumann282018-09-012021-02-11
Acoustic Cueing During Slow-wave Sleep as a Measure to Improve Motor Rehabilitation Outcome in Stroke Patients
melody during motor training and slow wave sleep, melody only during motor training - Stroke
Not applicableUnknownChristian Baumann122017-11-012020-11-20
Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease
Sodium Oxybate, Placebo - Sleep-wake Disturbances in Motor-phase Parkinson's Disease
Phase 2CompletedChristian Baumann162014-04-012021-01-25
Inhibiting COMT in Parkinson's Disease
Parkinson's Disease
WithdrawnChristian Baumann2014-02-012021-01-25
Cortical Excitability and Decision Making After Total Sleep Deprivation and Sleep Restriction
Sleep Deprivation - Acute and Partial Sleep Deprivation
Not applicableCompletedChristian Baumann142013-05-012020-11-20
Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment
Pyridostigmine bromide, fludrocortisone - Autonomic Disturbances in Parkinson's Disease
Phase 2CompletedChristian Baumann182012-06-012021-01-25

Conditions studied

Parkinson Disease (4)  ·  Nerve Degeneration (2)  ·  Cognitive Dysfunction (1)  ·  Disorders of Excessive Somnolence (1)  ·  Huntington Disease (1)  ·  Stroke (1)

Interventions

Acoustic Stimulation (2)  ·  Fludrocortisone (1)  ·  Pyridostigmine Bromide (1)  ·  Sleep, Slow-Wave (1)  ·  Sodium Oxybate (1)  ·  fludrocortisone acetate (1)

Countries

Switzerland (8)

Top investigators

Christian R Baumann, MD (1)

Results publications

PMID 28224720, PMID 29114733, PMID 42191834

NIH funding

2017 (1)